Skip to main content

Advertisement

Figure 2 | Breast Cancer Research

Figure 2

From: Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer

Figure 2

Correlation between CTC detection, TIMP-1 and patient outcome. (a) Progression-free survival. (b) Overall survival of metastatic breast cancer patients based on CTC positivity (≥ 5 CTC) and TIMP-1 serum levels. CTC, circulating tumor cell; TIMP, tissue inhibitor of metalloproteinase.

Back to article page